72 research outputs found

    Understanding space weather to shield society: A global road map for 2015-2025 commissioned by COSPAR and ILWS

    Get PDF
    There is a growing appreciation that the environmental conditions that we call space weather impact the technological infrastructure that powers the coupled economies around the world. With that comes the need to better shield society against space weather by improving forecasts, environmental specifications, and infrastructure design. [...] advanced understanding of space weather requires a coordinated international approach to effectively provide awareness of the processes within the Sun-Earth system through observation-driven models. This roadmap prioritizes the scientific focus areas and research infrastructure that are needed to significantly advance our understanding of space weather of all intensities and of its implications for society. Advancement of the existing system observatory through the addition of small to moderate state-of-the-art capabilities designed to fill observational gaps will enable significant advances. Such a strategy requires urgent action: key instrumentation needs to be sustained, and action needs to be taken before core capabilities are lost in the aging ensemble. We recommend advances through priority focus (1) on observation-based modeling throughout the Sun-Earth system, (2) on forecasts more than 12 hrs ahead of the magnetic structure of incoming coronal mass ejections, (3) on understanding the geospace response to variable solar-wind stresses that lead to intense geomagnetically-induced currents and ionospheric and radiation storms, and (4) on developing a comprehensive specification of space climate, including the characterization of extreme space storms to guide resilient and robust engineering of technological infrastructures. The roadmap clusters its implementation recommendations by formulating three action pathways, and outlines needed instrumentation and research programs and infrastructure for each of these. [...]Comment: In press for Advances of Space Research: an international roadmap on the science of space weather, commissioned by COSPAR and ILWS (63 pages and 4 figures

    A chemical survey of exoplanets with ARIEL

    Get PDF
    Thousands of exoplanets have now been discovered with a huge range of masses, sizes and orbits: from rocky Earth-like planets to large gas giants grazing the surface of their host star. However, the essential nature of these exoplanets remains largely mysterious: there is no known, discernible pattern linking the presence, size, or orbital parameters of a planet to the nature of its parent star. We have little idea whether the chemistry of a planet is linked to its formation environment, or whether the type of host star drives the physics and chemistry of the planet’s birth, and evolution. ARIEL was conceived to observe a large number (~1000) of transiting planets for statistical understanding, including gas giants, Neptunes, super-Earths and Earth-size planets around a range of host star types using transit spectroscopy in the 1.25–7.8 μm spectral range and multiple narrow-band photometry in the optical. ARIEL will focus on warm and hot planets to take advantage of their well-mixed atmospheres which should show minimal condensation and sequestration of high-Z materials compared to their colder Solar System siblings. Said warm and hot atmospheres are expected to be more representative of the planetary bulk composition. Observations of these warm/hot exoplanets, and in particular of their elemental composition (especially C, O, N, S, Si), will allow the understanding of the early stages of planetary and atmospheric formation during the nebular phase and the following few million years. ARIEL will thus provide a representative picture of the chemical nature of the exoplanets and relate this directly to the type and chemical environment of the host star. ARIEL is designed as a dedicated survey mission for combined-light spectroscopy, capable of observing a large and well-defined planet sample within its 4-year mission lifetime. Transit, eclipse and phase-curve spectroscopy methods, whereby the signal from the star and planet are differentiated using knowledge of the planetary ephemerides, allow us to measure atmospheric signals from the planet at levels of 10–100 part per million (ppm) relative to the star and, given the bright nature of targets, also allows more sophisticated techniques, such as eclipse mapping, to give a deeper insight into the nature of the atmosphere. These types of observations require a stable payload and satellite platform with broad, instantaneous wavelength coverage to detect many molecular species, probe the thermal structure, identify clouds and monitor the stellar activity. The wavelength range proposed covers all the expected major atmospheric gases from e.g. H2O, CO2, CH4 NH3, HCN, H2S through to the more exotic metallic compounds, such as TiO, VO, and condensed species. Simulations of ARIEL performance in conducting exoplanet surveys have been performed – using conservative estimates of mission performance and a full model of all significant noise sources in the measurement – using a list of potential ARIEL targets that incorporates the latest available exoplanet statistics. The conclusion at the end of the Phase A study, is that ARIEL – in line with the stated mission objectives – will be able to observe about 1000 exoplanets depending on the details of the adopted survey strategy, thus confirming the feasibility of the main science objectives.Peer reviewedFinal Published versio

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    Get PDF
    Aims  The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. Low-density lipoprotein cholesterol (LDL-C) reduction with statins and proprotein convertase subtilisin–kexin Type 9 (PCSK9) inhibitors reduces risk of MI, but less is known about effects on types of MI. ODYSSEY OUTCOMES compared the PCSK9 inhibitor alirocumab with placebo in 18 924 patients with recent acute coronary syndrome (ACS) and elevated LDL-C (≥1.8 mmol/L) despite intensive statin therapy. In a pre-specified analysis, we assessed the effects of alirocumab on types of MI. Methods and results  Median follow-up was 2.8 years. Myocardial infarction types were prospectively adjudicated and classified. Of 1860 total MIs, 1223 (65.8%) were adjudicated as Type 1, 386 (20.8%) as Type 2, and 244 (13.1%) as Type 4. Few events were Type 3 (n = 2) or Type 5 (n = 5). Alirocumab reduced first MIs [hazard ratio (HR) 0.85, 95% confidence interval (CI) 0.77–0.95; P = 0.003], with reductions in both Type 1 (HR 0.87, 95% CI 0.77–0.99; P = 0.032) and Type 2 (0.77, 0.61–0.97; P = 0.025), but not Type 4 MI. Conclusion  After ACS, alirocumab added to intensive statin therapy favourably impacted on Type 1 and 2 MIs. The data indicate for the first time that a lipid-lowering therapy can attenuate the risk of Type 2 MI. Low-density lipoprotein cholesterol reduction below levels achievable with statins is an effective preventive strategy for both MI types.For complete list of authors see http://dx.doi.org/10.1093/eurheartj/ehz299</p

    Effect of alirocumab on mortality after acute coronary syndromes. An analysis of the ODYSSEY OUTCOMES randomized clinical trial

    Get PDF
    Background: Previous trials of PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitors demonstrated reductions in major adverse cardiovascular events, but not death. We assessed the effects of alirocumab on death after index acute coronary syndrome. Methods: ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) was a double-blind, randomized comparison of alirocumab or placebo in 18 924 patients who had an ACS 1 to 12 months previously and elevated atherogenic lipoproteins despite intensive statin therapy. Alirocumab dose was blindly titrated to target achieved low-density lipoprotein cholesterol (LDL-C) between 25 and 50 mg/dL. We examined the effects of treatment on all-cause death and its components, cardiovascular and noncardiovascular death, with log-rank testing. Joint semiparametric models tested associations between nonfatal cardiovascular events and cardiovascular or noncardiovascular death. Results: Median follow-up was 2.8 years. Death occurred in 334 (3.5%) and 392 (4.1%) patients, respectively, in the alirocumab and placebo groups (hazard ratio [HR], 0.85; 95% CI, 0.73 to 0.98; P=0.03, nominal P value). This resulted from nonsignificantly fewer cardiovascular (240 [2.5%] vs 271 [2.9%]; HR, 0.88; 95% CI, 0.74 to 1.05; P=0.15) and noncardiovascular (94 [1.0%] vs 121 [1.3%]; HR, 0.77; 95% CI, 0.59 to 1.01; P=0.06) deaths with alirocumab. In a prespecified analysis of 8242 patients eligible for ≥3 years follow-up, alirocumab reduced death (HR, 0.78; 95% CI, 0.65 to 0.94; P=0.01). Patients with nonfatal cardiovascular events were at increased risk for cardiovascular and noncardiovascular deaths (P<0.0001 for the associations). Alirocumab reduced total nonfatal cardiovascular events (P<0.001) and thereby may have attenuated the number of cardiovascular and noncardiovascular deaths. A post hoc analysis found that, compared to patients with lower LDL-C, patients with baseline LDL-C ≥100 mg/dL (2.59 mmol/L) had a greater absolute risk of death and a larger mortality benefit from alirocumab (HR, 0.71; 95% CI, 0.56 to 0.90; Pinteraction=0.007). In the alirocumab group, all-cause death declined wit h achieved LDL-C at 4 months of treatment, to a level of approximately 30 mg/dL (adjusted P=0.017 for linear trend). Conclusions: Alirocumab added to intensive statin therapy has the potential to reduce death after acute coronary syndrome, particularly if treatment is maintained for ≥3 years, if baseline LDL-C is ≥100 mg/dL, or if achieved LDL-C is low. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01663402

    On the reading of, [hieroglyph], as "ny-sw·t"

    No full text
    Source: Tirage à part du Recueil de travaux relatifs à la philologie et à l'archèologie ègyptiennes et assyriennes, (1916) vol. 38.Hieroglyph in title is unable to be transcribed.On the reading of, [heiroglyph], as "ny-sw·t" -- Additional note on A. M. Blackman's article.Electronic reproduction.p. [1-2] 30 c

    The Design of Value Added Services to Serve ESPAS Users

    Get PDF
    The primary objective of ESPAS is to support the access to observations from the near‐Earth space environment. This is a region that extends from the Eart's atmosphere up to the inner magnetosphere. Observing instruments that are linked to ESPAS include ionosondes, incoherent scatter radars, magnetometers, GNSS receivers and a large number of space sensors and radars. The ESPAS platform supports the systematic exploration of multi‐point measurements from near‐Earth space through homogeneous access to diverse data, enhances researchers' capability to develop advanced models of the geospace, supports data assimilation and provides tools for validation of models. Although the system development is in its early phase, the consortium has already started to analyse indicative scientific problems, whose study will be possible through the use of ESPAS services. The scientific advances resulting from these studies will lead to the development of validated scientific models and consequently to reliable predictions and related products and value‐added services that will meet the needs of scientists, operators, decision makers, system developers, etc. An important work done within the ESPAS project is the definition of several scientific scenarios called "use cases". The "use cases" express the user requirements on the ESPAS system, in other words they express "what" the system should be able to perform. These scenarios are exploring the required behaviour of ESPAS and form a solid basis for testing the system's behaviour as it responds to a request that originates from outside of the system. The following main groups of use cases are under analysis and first results will be reported in the ESWW10: a) Homogenised access to the main ESPAS data repositories b) coincidences and conjunctions between groundspace and space‐space monitoring units c) tools to validate models d) on line implementation of models able to support space weather prediction services

    Neural, Cognitive, and Clinical Effects of Prefrontal Cortex Stimulation in Depression Combined with Psychological Therapy: A Double-Blind Randomized Controlled Trial

    No full text
    Transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC) has recently shown efficacy as a treatment for depression. We combined tDCS with psychological therapy to determine whether tDCS of the DLPFC could enhance therapeutic outcome in depression

    By Our Selves

    No full text
    By Our Selves documents a four-day walk made by the English Poet John Clare from an asylum in the Epping Forest up into Northamptonshire. Toby Jones, Iain Sinclair and a Straw Bear follow in his footsteps exactly 150 years after his death. En route they bump into Highland musician and poet MacGillivray, and graphic novelist Alan Moore. Captured in black &amp; white photography, they discover the only truth of the road: whatever our hopes and delusions, we are always By Our Selves

    Cassini observations of ionospheric photoelectrons at large distances from Titan: implications for Titan's exospheric environment and magnetic tail

    No full text
    Discrete peaks near 24.1 eV are seen in electron spectra measured in Titan's ionosphere by the ELS (Electron Spectrometer), part of the Cassini Plasma Spectrometer (CAPS), and are interpreted as photoelectrons. These photoelectrons are generated as a result of ionization of N2 by the strong solar He II (30.4 nm) line. They are generally observed in the dayside ionosphere, because this is where neutral N2 particles can be ionized by solar radiation. Coates et al. (2007) discussed initial observations of photoelectrons in Titan's distant tail during the T9 encounter. Here, we describe additional photoelectron peak observations at large distances from Titan, where they are unlikely to have originated because of low neutral N2 densities. We consider the tail structures during the encounters T15, T17, and T40. We infer that the distant photoelectrons may have traveled to the observation sites by means of a magnetic connection from lower altitudes in the dayside ionosphere, where they could have been produced. This idea is supported by results of hybrid modeling. Thus photoelectrons may be used as tracers of magnetic field lines and further improve our understanding of Titan's complex plasma environment
    corecore